A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit <a rel="external noopener" href="https://www.dovepress.com/front_end/cr_data/cache/pdf/download_1611397809_600bfab17c682/opth-278169-phentolamine-mesylate-ophthalmic-solution-provides-lasting-p.pdf">the original URL</a>. The file type is <code>application/pdf</code>.
<i title="Informa UK Limited">
<a target="_blank" rel="noopener" href="https://fatcat.wiki/container/kfvcq6rwnnaphiolds76t5szvu" style="color: black;">Clinical Ophthalmology</a>
Phentolamine mesylate ophthalmic solution (PMOS), applied to the eye topically, was shown previously to have beneficial effects in patients with dim light vision disturbances (DLD), including decreased pupil diameter (PD), improved best-corrected distance visual acuity (BCDVA), as well as lower intraocular pressure (IOP). The ORION-1 trial evaluated the long-term safety and efficacy of PMOS in a glaucomatous, presbyopic population. In this randomized, double-masked, multi-center,<span class="external-identifiers"> <a target="_blank" rel="external noopener noreferrer" href="https://doi.org/10.2147/opth.s278169">doi:10.2147/opth.s278169</a> <a target="_blank" rel="external noopener" href="https://www.ncbi.nlm.nih.gov/pubmed/33447013">pmid:33447013</a> <a target="_blank" rel="external noopener" href="https://pubmed.ncbi.nlm.nih.gov/PMC7802916/">pmcid:PMC7802916</a> <a target="_blank" rel="external noopener" href="https://fatcat.wiki/release/5b45vy5fojhmjokqrl326vsfd4">fatcat:5b45vy5fojhmjokqrl326vsfd4</a> </span>
more »... led, multiple-dose Phase 2b trial, 39 patients with elevated IOP were randomized to receive one evening dose of study medication or placebo for 14 days. The primary outcome measure was mean change in diurnal IOP, and the key secondary outcome measures included changes in PD, distance-corrected near visual acuity (DCNVA), and conjunctival hyperemia. Use of 1% PMOS did not lead to a statistically significant decrease in diurnal IOP compared to placebo (P = 0.89) but trended toward a greater decrease in patients with lower IOP baselines. PMOS produced a statistically significant mean 20% PD reduction under both photopic and mesopic conditions that was sustained for 36 hours post-dosing. A statistically significant number of patients with PMOS compared to placebo demonstrated ≥1 line of improvement in photopic DCNVA at day 8 (P = 0.0018), day 15 (P = 0.0072), and day 16 (P = 0.0163), with a trend for 2- and 3-line improvements at all time points. There was no statistical difference in conjunctival hyperemia compared to placebo. Although mean IOP was not lowered significantly, daily evening dosing of 1% PMOS was found to be well tolerated with no daytime conjunctival redness and demonstrated improvement in DCNVA with sustained PD reduction in a glaucomatous and presbyopic population. Smaller pupil size can have beneficial effects in improving symptoms of presbyopia and DLD, which will be the focus of further studies.
<a target="_blank" rel="noopener" href="https://web.archive.org/web/20210123103009/https://www.dovepress.com/front_end/cr_data/cache/pdf/download_1611397809_600bfab17c682/opth-278169-phentolamine-mesylate-ophthalmic-solution-provides-lasting-p.pdf" title="fulltext PDF download" data-goatcounter-click="serp-fulltext" data-goatcounter-title="serp-fulltext"> <button class="ui simple right pointing dropdown compact black labeled icon button serp-button"> <i class="icon ia-icon"></i> Web Archive [PDF] <div class="menu fulltext-thumbnail"> <img src="https://blobs.fatcat.wiki/thumbnail/pdf/1e/4b/1e4b0d02bd5dfe6eeb57bdad5bf365d853b46e62.180px.jpg" alt="fulltext thumbnail" loading="lazy"> </div> </button> </a> <a target="_blank" rel="external noopener noreferrer" href="https://doi.org/10.2147/opth.s278169"> <button class="ui left aligned compact blue labeled icon button serp-button"> <i class="unlock alternate icon" style="background-color: #fb971f;"></i> Publisher / doi.org </button> </a> <a target="_blank" rel="external noopener" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802916" title="pubmed link"> <button class="ui compact blue labeled icon button serp-button"> <i class="file alternate outline icon"></i> pubmed.gov </button> </a>